Fereidoun Mahboudi

T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: Towards tumor-directed oligoclonal T cell therapy

Fatemeh Rahimi Jamnani, Fatemeh Rahbarizadeh, Mohammad Ali Shokrgozar et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2013 · 89 citations

Cell Therapy, Tumor Immunology, T Cells +6

Genetically engineered T cells bearing chimeric nanoconstructed receptors harboring TAG-72-specific camelid single domain antibodies as targeting agents

Zahra Sharifzadeh, Fatemeh Rahbarizadeh, Mohammad Ali Shokrgozar et al. · Cancer Letters · 2012 · 74 citations

T Cells, Immunoengineering, Immunology +8

Designed Amino Acid Feed in Improvement of Production and Quality Targets of a Therapeutic Monoclonal Antibody

Fatemeh Torkashvand, Behrouz Vaziri, Shayan Maleknia et al. · PLoS ONE · 2015 · 69 citations · Full text

Engineering, Amino Acids, Glycobiology +19

<b><i>Leishmaniasis recidivans</i> among school children in Bam, South‐east Iran, 1994–2006</b>

Iraj Sharifi, Alireza Fekri, Mohammad Reza Aflatoonian et al. · International Journal of Dermatology · 2010 · 58 citations

Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells

Fatemeh Rahimi Jamnani, Fatemeh Rahbarizadeh, Mohammad Ali Shokrgozar et al. · Experimental Cell Research · 2012 · 53 citations

Tumor Biology, Protein Nanoparticles, Tumor Targeting +7